NASDAQ:TNXP
Tonix Pharmaceuticals Stock News
$0.171
-0.0059 (-3.33%)
At Close: May 02, 2024
Are Penny Stocks Worth Investing In This Month? 3 To Watch Under $1
03:30pm, Sunday, 03'rd Apr 2022 PennyStocks
Check these 3 penny stocks out for your watchlist this month
The post Are Penny Stocks Worth Investing In This Month? 3 To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Informa
Are Penny Stocks Worth Investing In This Month? 3 To Watch Under $1
11:30am, Sunday, 03'rd Apr 2022
Check these 3 penny stocks out for your watchlist this month The post Are Penny Stocks Worth Investing In This Month? 3 To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Informa
3 Penny Stocks That You Need to Add to Your List This Week
09:58pm, Tuesday, 29'th Mar 2022 PennyStocks
Are these penny stocks on your watchlist right now or not?
The post 3 Penny Stocks That You Need to Add to Your List This Week appeared first on Penny Stocks to Buy, Picks, News and Information | Penn
Executives Buy More Than $1M Of 5 Penny Stocks
06:16pm, Tuesday, 29'th Mar 2022 Benzinga
The Dow Jones jumped around 200 points on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around
3 Penny Stocks That You Need to Add to Your List This Week
05:58pm, Tuesday, 29'th Mar 2022
Are these penny stocks on your watchlist right now or not? The post 3 Penny Stocks That You Need to Add to Your List This Week appeared first on Penny Stocks to Buy, Picks, News and Information | Penn
Executives Buy More Than $1M Of 5 Penny Stocks
02:25pm, Tuesday, 29'th Mar 2022
The Dow Jones jumped around 200 points on Tuesday. Investors, meanwhile, focused on some notable insider trades.
Tonix Pharmaceuticals Announces Phase 3 RALLY Study Results for TNX-102 SL 5.6 mg for the Management of Fibromyalgia
11:00am, Monday, 21'st Mar 2022 GlobeNewswire Inc.
As Expected Based on Interim Analysis Results Reported in July 2021, TNX-102 SL Did Not Achieve Statistical Significance Over Placebo on the Primary Endpoint of Reduction in Daily Pain in RALLY Study
Tonix Says Fibromyalgia Candidate Failed To Achieve Statistical Significance Over Placebo
10:20am, Monday, 21'st Mar 2022
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) says that as expected, TNX-102 SL (cyclobenzaprine HCl sublingual tablets) did not significantly reduce fibromyalgia daily pain at Week 14 compared
Tonix Pharmaceuticals: Q4 Earnings Insights
12:11pm, Monday, 14'th Mar 2022 Benzinga
Tonix Pharmaceuticals (NASDAQ: TNXP ) reported its Q4 earnings results on Monday, March 14, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Tonix Pharmaceuticals missed estimated earnings by 16.67%, reporting … Full story available on Benzinga.com
Tonix Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01 (NASDAQ:TNXP)
11:04am, Monday, 14'th Mar 2022 Seeking Alpha
Tonix Pharmaceuticals press release (TNXP): Q4 GAAP EPS of -$0.07 misses by $0.01.As of December 30, 2021, Tonix had $178.7 million of cash and cash equivalents
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
11:00am, Monday, 14'th Mar 2022 GlobeNewswire Inc.
Immunology and CNS Programs Entering the Clinic in 2022 for Organ Transplantation, Cocaine Intoxication, Fibromyalgia, PTSD, Migraine Headache and Binge Eating Disorder
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
11:00am, Monday, 14'th Mar 2022 GlobeNewswire
Immunology and CNS Programs Entering the Clinic in 2022 for Organ Transplantation, Cocaine Intoxication, Fibromyalgia, PTSD, Migraine Headache and Binge Eating Disorder
Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld, Ph.D., as Executive Director, Genomics and Bioinformatics
12:00pm, Wednesday, 09'th Mar 2022 GlobeNewswire Inc.
CHATHAM, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointme
Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld, Ph.D., as Executive Director, Genomics and Bioinformatics
12:00pm, Wednesday, 09'th Mar 2022 GlobeNewswire
CHATHAM, N.J., March 09, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the appointment of Jeffrey Rosenfeld, Ph.D., as its new Executive Director, Genomics and Bioinformatics. In this role, Dr. Rosenfeld will direct Tonix’s pharmacogenomics efforts including applying artificial intelligence, genome-wide association studies and mathematical modeling techniques to the analysis of patient outcomes in Tonix’s clinical trials.
Thinking about buying stock in VEON, Nio, Transocean, Clover Health Investments, or Tonix Pharmaceuticals?
03:50pm, Monday, 07'th Mar 2022 Benzinga
NEW YORK , March 7, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VEON, NIO, RIG, CLOV, and TNXP. … Full story available on Benzinga.com